Meridian launches a high-fidelity polymerase

Create PDF

“In NGS-based clinical assays, being able to sequence all the DNA regions of the sample independently from GC content is essential,” Florent Chang-Pi-Hin, PhD, senior director of research and development at Meridian, said in a press release. “Using our extensive expertise in enzymes and buffer systems, High-Specificity Pfu HS Mix has been designed to achieve this. From target enrichment to library amplification, it allows better NGS data and more accurate results.”